Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.26 (
GSK
)
6,788
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dendritic arborization and axon outgrowth are critical steps in the establishment of neural connectivity in the developing brain. Changes in the connectivity underlie cognitive dysfunction in neurodevelopmental disorders. However, molecules and associated mechanisms that play important roles in dendritic and axon outgrowth in the brain are only partially understood. Here, we show that
microtubule-actin crosslinking factor 1
(
MACF1
) regulates dendritic arborization and axon outgrowth of developing pyramidal neurons by arranging cytoskeleton components and mediating
GSK
-3 signaling.
MACF1
deletion using conditional mutant mice and in utero gene transfer in the developing brain markedly decreased dendritic branching of cortical and hippocampal pyramidal neurons.
MACF1
-deficient neurons showed reduced density and aberrant morphology of dendritic spines. Also, loss of
MACF1
impaired the elongation of callosal axons in the brain. Actin and microtubule arrangement appeared abnormal in
MACF1
-deficient neurites. Finally, we found that
GSK
-3 is associated with
MACF1
-controlled dendritic differentiation. Our findings demonstrate a novel role for
MACF1
in neurite differentiation that is critical to the creation of neuronal connectivity in the developing brain.
...
PMID:Microtubule-Actin Crosslinking Factor 1 Is Required for Dendritic Arborization and Axon Outgrowth in the Developing Brain. 2652 44